Akba stock price

Based on 5 analysts offering 12 month price targets for Akebia Therapeutics in the last 3 months. The average price target is $13.80 with a high forecast of  Heat Biologics Takes Beating After Pricing $12 Million Stock Offering · By Rob Lenihan. Nov 21, 2018 3:21 PM EST. We apologize for any inconvenience. Company Name: Akebia Therapeutics. Inc., Stock Symbol: AKBA, Industry: Biotechs, Total Posts: 76, Last Post: 1/15/2020 3:59:12 PM. Top trades and best-performing strategies with Akebia Therapeutics, Inc. $AKBA supported by the most actionable news from the market. 7 Feb 2020 But if you pick the right individual stocks, you could make more than that. To wit, the Akebia Therapeutics, Inc. (NASDAQ:AKBA) share price is  Akebia Therapeutics Stock Price Forecast, AKBA stock price prediction. The best long-term & short-term Akebia Therapeutics share price prognosis for 2020,  Stock quote and company snapshot for AKEBIA THERAPEUTICS INC (AKBA), including profile, stock chart, Price Performance (Last 52 Weeks), -6.01%.

Based on 5 analysts offering 12 month price targets for Akebia Therapeutics in the last 3 months. The average price target is $13.80 with a high forecast of 

Is Akebia Therapeutics (NASDAQ:AKBA) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and  Current Technical Analysis and interactive chart for $AKBA stock / shares. The stock exhibited some range contraction during this trading session as price  24 Feb 2020 The 52-week price high and low points are important variables to concentrate on when assessing the current and prospective worth of a stock. 5 brokers rate it as a 'Buy'. Click to view NMQ:AKBA's StockReport. Momentum · StockRank™ · StockReport™. Tools Price to Free Cashflow · Price to Sales. Current, Vs Industry, Vs History. 3-Year Average Share Buyback Ratio, -45.3. Valuation & Return. Current, Vs Industry, Vs History. Price-to-Tangible-Book, 16.34. 19 Mar 2020 Akebia Therapeutics (AKBA) Gets a Buy Rating from Mizuho Securities also reiterated a Buy rating on the stock with a $15.00 price target.

24 Feb 2020 The 52-week price high and low points are important variables to concentrate on when assessing the current and prospective worth of a stock.

4 equities research analysts have issued 12-month target prices for Akebia Therapeutics' shares. Their forecasts range from $13.00 to $16.00. On average, they  Review AKBA revenue, net income, and cash flow. Start a 14-day free trial to Morningstar Premium to unlock full historical Stocks by Morningstar Classification  Akebia Therapeutics (NASDAQ: AKBA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and  Based on 5 analysts offering 12 month price targets for Akebia Therapeutics in the last 3 months. The average price target is $13.80 with a high forecast of  Heat Biologics Takes Beating After Pricing $12 Million Stock Offering · By Rob Lenihan. Nov 21, 2018 3:21 PM EST. We apologize for any inconvenience. Company Name: Akebia Therapeutics. Inc., Stock Symbol: AKBA, Industry: Biotechs, Total Posts: 76, Last Post: 1/15/2020 3:59:12 PM. Top trades and best-performing strategies with Akebia Therapeutics, Inc. $AKBA supported by the most actionable news from the market.